Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amag Pharmaceuticals (AMAG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 439,814
  • Shares Outstanding, K 34,713
  • Annual Sales, $ 474,000 K
  • Annual Income, $ -65,760 K
  • 60-Month Beta 0.44
  • Price/Sales 0.93
  • Price/Cash Flow 8.01
  • Price/Book 0.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.74
  • Number of Estimates 2
  • High Estimate -0.53
  • Low Estimate -0.94
  • Prior Year -1.59
  • Growth Rate Est. (year over year) +53.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.70 +16.36%
on 03/08/19
16.88 -26.24%
on 02/19/19
-4.26 (-25.49%)
since 02/15/19
3-Month
10.70 +16.36%
on 03/08/19
17.39 -28.41%
on 01/22/19
-4.02 (-24.41%)
since 12/18/18
52-Week
10.70 +16.36%
on 03/08/19
26.10 -52.30%
on 08/13/18
-7.45 (-37.44%)
since 03/16/18

Most Recent Stories

More News
Downtrend Call Working As Amag Pharmaceuti Stock Falls 29.3% (AMAG)

SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 4 months, Amag Pharmaceuti has returned 29.29% as of today's recent price of $12.65....

AMAG : 12.45 (-1.74%)
Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News

Key highlights of the past week are regulatory and pipeline developments.

CELG : 87.99 (-0.53%)
VRTX : 187.48 (-0.32%)
ZFGN : 3.06 (+1.66%)
AMAG : 12.45 (-1.74%)
REGN : 407.60 (-1.66%)
SNY : 44.91 (-0.40%)
Amag Pharmaceuti has the Best Relative Performance in the Biotechnology Industry (AMAG , NVTA , NTRA , EXAS , BLUE )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

NVTA : 24.19 (-0.37%)
NTRA : 19.75 (+1.80%)
AMAG : 12.45 (-1.74%)
AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study

Shares of AMAG (AMAG) decline almost 17% after the company's pregnancy drug, Makena fails in the post approval PROLONG study.

CELG : 87.99 (-0.53%)
BDSI : 4.91 (-1.41%)
ATRS : 3.49 (-0.29%)
AMAG : 12.45 (-1.74%)
Why Is AMAG Pharmaceuticals (AMAG) Down 24.5% Since Last Earnings Report?

AMAG Pharmaceuticals (AMAG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AMAG : 12.45 (-1.74%)
Amag Pharmaceuti Falls 20.55% on Heavy Volume: Watch For Potential Rebound

Amag Pharmaceuti (NASDAQ:AMAG) traded in a range yesterday that spanned from a low of $10.90 to a high of $13.84. Yesterday, the shares fell 20.6%, which took the trading range below the 3-day low of...

AMAG : 12.45 (-1.74%)
AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena(R) (hydroxyprogesterone caproate injection)

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today topline results from PROLONG (Progestin's Role in Optimizing Neonatal Gestation), a randomized, double-blinded, placebo-controlled clinical trial...

AMAG : 12.45 (-1.74%)
Shares of AMAG Down 22.7% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 4 months, Amag Pharmaceuti has returned 22.69% as of today's recent price of $13.83....

AMAG : 12.45 (-1.74%)
AMAG Pharmaceuticals Presents New Data on Bremelanotide and Hypoactive Sexual Desire Disorder at the ISSWSH/ISSM Joint Meeting

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that new and encore data related to bremelanotide and Hypoactive Sexual Desire Disorder (HSDD) will be presented at the upcoming International Society...

AMAG : 12.45 (-1.74%)
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the following investor conferences during the month of March:

AMAG : 12.45 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade AMAG with:

Business Summary

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the...

See More

Key Turning Points

2nd Resistance Point 13.00
1st Resistance Point 12.72
Last Price 12.45
1st Support Level 12.30
2nd Support Level 12.16

See More

52-Week High 26.10
Fibonacci 61.8% 20.22
Fibonacci 50% 18.40
Fibonacci 38.2% 16.58
Last Price 12.45
52-Week Low 10.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar